Pharmacokinetics, Pharmacodynamics, Bioequivalence
As a service to the pharmaceutical industry, we investigate the pharmacokinetics (PK) and pharmacodynamics (PD) of new drugs as well as the bioequivalence (BE) of new pharmaceutical formulations. We also carry out biomarker-based and metabolomic studies to pinpoint the causes of inflammatory diseases. We perform preclinical ex vivo and in vivo, as well as clinical in vivo, studies. During these studies, we use microdialysis and our patented Open Flow Microperfusion (OFM).
Technologies for Regenerative Medicine
Smart functional GLA nanoformulation for Fabry disease
Improved diagnosis and treatment for neurodegenerative diseases by directly accessing tissues in the brain
PK-PD of Antibody:
Pharmacokinetics und pharmacodynamics of an antibody in the skin of healthy volunteers and psoriatric patients
Bioequivalence of drugs in the skin